dsaur0, they only way for Sony to start to get their money back is to sell the darn things, weather they put it their own products or sell to other OEM's. And 8 years of selling our tech with their sales force is music to my ears. I originally thought it might be a four year deal. The more responsibility they assume the better I like it. Sony has a lot to return to their shareholders and it will play out well for us to be aboard. If we live long enough we should smile a lot.
He set the price at $8. Why pay more? The street knew this was coming and the price of the secondary.
It's always the same wisker, they take the shares back and then issue them to each other as bonuses. We get the bills they get rich. Partnerships are key and he stinks at securing them. Too many indications in the pipe not to focus on securing partners, we can never finance all we have on our plate ourselves, but he seems to be trying to stick it to us.
Pipeline too big not to have partners and nobody seems interested. Beating shareholders over and over isn't going to attract many long holders and his record stinks.
Makes me doubt if he has any mrkt savy. Didn't even give the pps time to recover from the Blackrock drubbing. Doesn't give retail holders much consideration. I didn't expect this until July, now I am thinking we have too much on our plates to finance ourselves and will have to pony up again within a year. WIthout partners this goes on forever as our pipeline is huge.
Feel the same way trader and I picked up more a month ago thinking it was eminent. Now i have doubts as to the results we will get.
Well, last July things didn't go so well for the P2 trial results even though it made management happy. I think they have a good indication of the Peer review right now, and this may be the telling clue.
The prostate snippet sounds remarkably like the P2 expected results last year. In fact, this seems to be his only way of taking this company forward. Last May an RS that crushed the pps followed by the P2 results that were less than stellar in the opinion of the street which punished this company for three consecutive weeks. The only thing that helped stop the crash was Dr. Kim buying over 2M in shares on the open market. Not a bad deal really as he and the BOD simply issue themselves those shares as bonuses and are made whole in short order.
This leads me to believe that the company is in worse shape than I thought. He didn't give the pps time to recover from the Blackrock pounding that went on for three months before lowering the boom on retail investors again. Makes me think that news similar to the P2 news last year is coming soon. Is the Peer Review at hand and will it be seen as another less than stellar report or perhaps one of our trials going south? The most important thing I see here is that Big Pharma is not coming aboard. Dr. Kim has shown little in the way of securing the financial help all small bio's need to attract small investors who look to partners to help with the burden. I still can't figure why Roche walked after paying all the up front money for 5150? We need money for the P3 and that's a given, but this is soo early in the game it looks like Kim is throwing in the towel on partnering as there is little interest. Anybody can issue shares and do RS's over and over and hand the bill to the investors. It's the ability to sell the tech and the science and the platform that is going to make the difference and so far he has shown almost nothing in that area.
What makes you think so. Nobody seems to be looking for Tokman to deliver anything. He is just getting it out of the way so he can stay silent for another 4 months or so. Orders over the next 60 to 90 days will tell us much more than Tokman has told us in the last ten years.
Well, after reading everyone's take on tomorrows CC I can readily see why the shorts are kicking #$%$ here and will do so tomorrow again. With all the celebrating over Picopro and picoair and the reviews etc., longs seem to be heading for another kick in the butt by the man once again. Maybe Sony will help.
NOt sure, but I think I have been hearing the not too distant future for many years now dealing with Alec Tokman. This is why the short interest is so high and they make money hand over fist.
Give it a break Geof, no more clout in this old ground. We all make a bad prediction or two in the years we've spent here paying the bills. Time to move on.
NOt worried. Only way for Sony to get any of it's investment back is to sell products, either their own or through someone else.